₹ 2,655.60
-72.10 (-2.64%)
G
GlaxoSmithKline Pharmaceuticals
₹ 2,655.60
GlaxoSmithKline Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of GlaxoSmithKline Pharmaceuticals as of Q2 Sep 2026 stands at ₹19.83. This is a 41.64% growth quarter on quarter and 31.59% growth same quarter last year. For the FY2026 the EPS of GlaxoSmithKline Pharmaceuticals stands at ₹61.15. This is a 11.67% growth compared with FY2025.
GlaxoSmithKline Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

